Atlassian Corp
For the period ended Jun 30, 2025. Filed Aug 15, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Aug 15, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Page | |
|---|---|
| Reports of Independent Registered Public Accounting Firm (PCAOB ID 42) | 63 |
| Consolidated Balance Sheets | 66 |
| Consolidated Statements of Operations | 67 |
| Consolidated Statements of Comprehensive Income (Loss) | 68 |
| Consolidated Statements of Stockholder’s Equity | 69 |
| Consolidated Statements of Cash Flows | 70 |
| Notes to Consolidated Financial Statements | 71 |
To the Stockholders and the Board of Directors of Atlassian Corporation
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Atlassian Corporation (the Company) as of June 30, 2025 and 2024, the related consolidated statements of operations, comprehensive income (loss), stockholders' equity and cash flows for each of the three years in the period ended June 30, 2025, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at June 30, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended June 30, 2025, in conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of June 30, 2025, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated August 15, 2025 expressed an unqualified opinion thereon.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matters
The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
| Revenue Recognition | |
| Description of the Matter | As described in Note 2 to the consolidated financial statements, the Company reports revenues in two categories: (i) subscriptions and (ii) other. The Company’s contracts often include promises to transfer multiple products and services to a customer. The Company allocates the transaction price for each contract to each performance obligation based on the relative standalone selling price (“SSP”) for each performance obligation.Auditing the Company’s revenue recognition was challenging due to the effort required to analyze the accounting treatment for contracts with multiple performance obligations. This involved assessing the impact of terms and conditions of contracts and the determination of SSP for the identified performance obligations. |
|---|
| How We Addressed the Matter in Our Audit | We obtained an understanding of the process for revenue recognition by performing a walkthrough. We also evaluated the design and tested the operating effectiveness of the Company's internal controls over the assessment of terms and conditions of contracts, which included the internal controls over the determination of SSP for the identified performance obligations.To evaluate management’s assessment of terms and conditions of contracts, we performed audit procedures that included, among others, testing a sample of contracts to understand the terms and conditions and evaluating SSP for the identified performance obligations. To evaluate management’s determination of SSP for the identified performance obligations, we performed audit procedures that included, among others, assessing the appropriateness of the methodologies used in the Company’s SSP analyses, testing the completeness and accuracy of the underlying data used, and testing the mathematical accuracy. Finally, we assessed the related disclosures in the consolidated financial statements. |
|---|
/s/Ernst & Young LLP
We have served as the Company’s auditor since 2012.
San Francisco, California
August 15, 2025
To the Stockholders and the Board of Directors of Atlassian Corporation
Opinion on Internal Control Over Financial Reporting
We have audited Atlassian Corporation’s internal control over financial reporting as of June 30, 2025, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Atlassian Corporation (the Company) maintained, in all material respects, effective internal control over financial reporting as of June 30, 2025, based on the COSO criteria.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the 2025 consolidated financial statements of the Company and our report dated August 15, 2025 expressed an unqualified opinion thereon.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Annual Report on internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.
Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ Ernst & Young LLP
San Francisco, California
August 15, 2025
(in thousands, except par value and share data)
| June 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $2,512,874 | $2,176,930 |
| Marketable securities | 424,268 | 161,973 |
| Accounts receivable, net | 778,302 | 628,049 |
| Prepaid expenses and other current assets | 175,793 | 109,312 |
| Total current assets | 3,891,237 | 3,076,264 |
| Non-current assets: | ||
| Property and equipment, net | 105,118 | 86,315 |
| Operating lease right-of-use assets | 169,127 | 172,468 |
| Strategic investments | 221,942 | 223,221 |
| Intangible assets, net | 244,840 | 299,057 |
| Goodwill | 1,304,445 | 1,288,756 |
| Deferred tax assets | 3,762 | 3,934 |
| Other non-current assets | 101,499 | 62,118 |
| Total assets | $6,041,970 | $5,212,133 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $222,092 | $177,545 |
| Accrued expenses and other current liabilities | 681,601 | 577,359 |
| Deferred revenue, current portion | 2,227,002 | 1,806,269 |
| Operating lease liabilities, current portion | 50,164 | 48,953 |
| Total current liabilities | 3,180,859 | 2,610,126 |
| Non-current liabilities: | ||
| Deferred revenue, net of current portion | 254,252 | 308,467 |
| Operating lease liabilities, net of current portion | 201,483 | 214,474 |
| Long-term debt | 987,684 | 985,911 |
| Deferred tax liabilities | 23,881 | 20,387 |
| Other non-current liabilities | 48,157 | 39,917 |
| Total liabilities | 4,696,316 | 4,179,282 |
| Commitments and contingencies (Note 11) | ||
| Stockholders’ equity | ||
| Class A Common Stock, $0.00001 par value; 750,000,000 shares authorized, 165,949,196 and 159,544,123 issued and outstanding at June 30, 2025 and 2024, respectively | 2 | 2 |
| Class B Common Stock, 0.00001 par value; 230,000,000 shares authorized, 97,030,987 and 101,012,393 issued and outstanding at June 30, 2025 and 2024, respectively | 1 | 1 |
| Additional paid-in capital | 5,574,290 | 4,212,064 |
| Accumulated other comprehensive income (loss) | 13,226 | 25,300 |
| Accumulated deficit | (4,241,865) | (3,204,516) |
| Total stockholders’ equity | 1,345,654 | 1,032,851 |
| Total liabilities and stockholders’ equity | $6,041,970 | $5,212,133 |
(in thousands, except per share data)
| Fiscal Year Ended June 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Revenues: | |||
| Subscription | $4,930,604 | $3,924,389 | $2,922,576 |
| Other | 284,700 | 434,214 | 612,071 |
| Total revenues | 5,215,304 | 4,358,603 | 3,534,647 |
| Cost of revenues (1) (2) | 894,851 | 803,495 | 633,765 |
| Gross profit | 4,320,453 | 3,555,108 | 2,900,882 |
| Operating expenses: | |||
| Research and development (1) (2) | 2,669,312 | 2,184,111 | 1,869,881 |
| Marketing and sales (1) (2) | 1,134,535 | 877,497 | 769,861 |
| General and administrative (1) | 646,998 | 610,577 | 606,362 |
| Total operating expenses | 4,450,845 | 3,672,185 | 3,246,104 |
| Operating loss | (130,392) | (117,077) | (345,222) |
| Other income (expense), net | (50,277) | (30,916) | 14,501 |
| Interest income | 112,324 | 96,663 | 49,732 |
| Interest expense | (30,550) | (34,077) | (30,147) |
| Loss before provision for income taxes | (98,895) | (85,407) | (311,136) |
| Provision for income taxes | (157,792) | (215,112) | (175,625) |
| Net loss | $(256,687) | $(300,519) | $(486,761) |
| Net loss per share attributable to Class A and Class B common stockholders: | |||
| Basic | $(0.98) | $(1.16) | $(1.90) |
| Diluted | $(0.98) | $(1.16) | $(1.90) |
| Weighted-average shares used in computing net income (loss) per share attributable to Class A and Class B common stockholders: | |||
| Basic | 261,787 | 259,133 | 256,307 |
| Diluted | 261,787 | 259,133 | 256,307 |
(1) Amounts include stock-based compensation, as follows:
| Cost of revenues | $83,017 | $71,691 | $63,913 |
|---|---|---|---|
| Research and development | 937,440 | 712,409 | 604,301 |
| Marketing and sales | 168,270 | 137,347 | 131,739 |
| General and administrative | 173,495 | 159,986 | 148,134 |
(2) Amounts include amortization of acquired intangible assets, as follows:
| Cost of revenues | $40,508 | $36,988 | $22,853 |
|---|---|---|---|
| Research and development | 374 | 374 | 374 |
| Marketing and sales | 14,635 | 12,386 | 9,900 |
| Fiscal Year Ended June 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Net loss | $(256,687) | $(300,519) | $(486,761) |
| Other comprehensive income (loss), net of reclassification adjustments: | |||
| Foreign currency translation adjustment | 3,639 | (2,270) | (5,283) |
| Net change in unrealized gain (loss) on marketable and privately held debt securities | 1,032 | 314 | 1,753 |
| Net gain (loss) on cash flow hedging derivative instruments | (16,745) | (6,746) | 23,668 |
| Other comprehensive income (loss), before tax | (12,074) | (8,702) | 20,138 |
| Income tax effect | — | — | — |
| Other comprehensive income (loss), net of tax | (12,074) | (8,702) | 20,138 |
| Total comprehensive income (loss), net of tax | $(268,761) | $(309,221) | $(466,623) |
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
| Common Stock · Additional paid in capital · Accumulated other comprehensive income (loss) · Accumulated deficit · Total stockholders’ equity | ||||||||
|---|---|---|---|---|---|---|---|---|
| Class A · Class B | ||||||||
| Shares · Amount · Shares · Amount | ||||||||
| Balance at June 30, 2022 | $144,820 | $1 | $110,036 | $1 | $2,182,536 | $13,864 | $(1,869,030) | $327,372 |
| Common stock issued | 3,684 | 1 | — | — | 8 | — | — | 9 |
| Conversion from Class B Common Stock to Class A Common Stock | 4,912 | — | (4,912) | — | — | — | — | — |
| Stock-based compensation | — | — | — | — | 948,087 | — | — | 948,087 |
| Repurchases of Class A Common Stock | (979) | — | — | — | — | — | (154,173) | (154,173) |
| Other comprehensive income (loss), net of tax | — | — | — | — | — | 20,138 | — | 20,138 |
| Net loss | — | — | — | — | — | — | (486,761) | (486,761) |
| Balance at June 30, 2023 | 152,437 | 2 | 105,124 | 1 | 3,130,631 | 34,002 | (2,509,964) | 654,672 |
| Common stock issued | 5,000 | — | — | — | — | — | — | — |
| Conversion from Class B Common Stock to Class A Common Stock | 4,112 | — | (4,112) | — | — | — | — | — |
| Stock-based compensation | — | — | — | — | 1,081,433 | — | — | 1,081,433 |
| Repurchases of Class A Common Stock | (2,161) | — | — | — | — | — | (394,033) | (394,033) |
| Other comprehensive income (loss), net of tax | — | — | — | — | — | (8,702) | — | (8,702) |
| Net loss | — | — | — | — | — | — | (300,519) | (300,519) |
| Balance at June 30, 2024 | 159,388 | 2 | 101,012 | 1 | 4,212,064 | 25,300 | (3,204,516) | 1,032,851 |
| Common stock issued | 6,473 | — | — | — | 4 | — | — | 4 |
| Conversion from Class B Common Stock to Class A Common Stock | 3,981 | — | (3,981) | — | — | — | — | — |
| Stock-based compensation | — | — | — | — | 1,362,222 | — | — | 1,362,222 |
| Repurchases of Class A Common Stock | (3,982) | — | — | — | — | — | (780,662) | (780,662) |
| Other comprehensive income (loss), net of tax | — | — | — | — | — | (12,074) | — | (12,074) |
| Net loss | — | — | — | — | — | — | (256,687) | (256,687) |
| Balance at June 30, 2025 | $165,860 | $2 | $97,031 | $1 | $5,574,290 | $13,226 | $(4,241,865) | $1,345,654 |
| Fiscal Year Ended June 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Cash flows from operating activities: | |||
| Net loss | $(256,687) | $(300,519) | $(486,761) |
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||
| Depreciation and amortization | 92,375 | 78,738 | 60,923 |
| Stock-based compensation | 1,362,222 | 1,081,433 | 948,087 |
| Impairment charges for leases and leasehold improvements | — | — | 61,098 |
| Deferred income taxes | 4,050 | 119 | 10,613 |
| Gain on a non-cash sale of a controlling interest of a subsidiary | — | (1,378) | (45,158) |
| Amortization of interest rate swap contracts | (26,344) | (4,166) | — |
| Net loss on strategic investments | 22,994 | 13,337 | 19,407 |
| Net foreign currency loss (gain) | (2,494) | 2,301 | (10,613) |
| Other | (532) | 1,305 | 1,959 |
| Changes in operating assets and liabilities, net of business combinations: | |||
| Accounts receivable, net | (150,035) | (148,469) | (169,526) |
| Prepaid expenses and other assets | (85,385) | (3,122) | (38,230) |
| Accounts payable | 42,873 | 18,150 | 78,902 |
| Accrued expenses and other liabilities | 90,988 | 158,123 | 74,611 |
| Deferred revenue | 366,368 | 552,307 | 362,799 |
| Net cash provided by operating activities | 1,460,393 | 1,448,159 | 868,111 |
| Cash flows from investing activities: | |||
| Business combinations, net of cash acquired | (14,245) | (847,767) | (5,775) |
| Purchases of property and equipment | (44,850) | (33,112) | (25,812) |
| Purchases of strategic investments | (27,430) | (14,400) | (19,450) |
| Purchases of marketable securities | (411,635) | (248,897) | (24,800) |
| Proceeds from maturities of marketable securities | 144,878 | 116,537 | 73,950 |
| Proceeds from sales of marketable securities | 5,893 | 41,514 | — |
| Proceeds from sales of strategic investments | 5,067 | 22,379 | 629 |
| Net cash used in investing activities | (342,322) | (963,746) | (1,258) |
| Cash flows from financing activities: | |||
| Repayment of Term Loan | — | (1,000,000) | — |
| Proceeds from issuance of debt, net of issuance cost | — | 987,039 | — |
| Repurchases of Class A Common Stock | (779,439) | (395,256) | (150,006) |
| Other | (3,143) | — | 1,585 |
| Net cash used in financing activities | (782,582) | (408,217) | (148,421) |
| Effect of foreign exchange rate changes on cash and cash equivalents | 151 | (1,989) | (1,805) |
| Net increase in cash, cash equivalents, and restricted cash | 335,640 | 74,207 | 716,627 |
| Cash, cash equivalents, and restricted cash at beginning of period | 2,178,122 | 2,103,915 | 1,386,686 |
| Net decrease in cash and cash equivalents included in assets held for sale | — | — | 602 |
| Cash, cash equivalents, and restricted cash at end of period | $2,513,762 | $2,178,122 | $2,103,915 |
| Reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above: | |||
| Cash and cash equivalents | $2,512,874 | $2,176,930 | $2,102,550 |
| Restricted cash included in other non-current assets | 888 | 1,192 | 1,365 |
| Total cash, cash equivalents, and restricted cash | $2,513,762 | $2,178,122 | $2,103,915 |
| Supplemental disclosures of cash flow information: | |||
|---|---|---|---|
| Income taxes paid, net of refunds | $180,470 | $253,828 | $102,156 |
| Interest paid | 54,268 | 61,339 | 46,247 |
| Received from interest rate swap contracts | — | (65,734) | (17,754) |
| Non-cash investing and financing activities: | |||
| Purchase of property and equipment included in accrued expenses and other current liabilities | 10,523 | 1,263 | 844 |
| Repurchases of Class A Common Stock included in accrued expenses and other current liabilities | 4,167 | 2,943 | 4,167 |
| Debt issuance costs included in accrued expenses and other current liabilities | — | 1,344 | — |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- Description of the Business
Atlassian Corporation (the “Company”) is a global technology company with a mission to unleash the potential of every team. The Company’s team collaboration software enables organizations to connect all teams through a system of work that unlocks productivity at scale. The Company’s portfolio of interconnected apps, AI agents, and products, each with discrete value propositions, delivers solutions for software teams, IT operations and support teams, and business teams.
The Company’s fiscal year ends on June 30 of each year. References to fiscal year 2025, for example, refer to the fiscal year ended June 30, 2025.
- Summary of Significant Accounting Policies
Basis of Preparation
The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). These principles are established primarily by the Financial Accounting Standards Board (“FASB”).
Certain reclassifications have been made to prior period balances to conform to the current period presentation. “Maintenance” revenues have been reclassified to “Other” revenues on the Company’s Consolidated Statements of Operations. This reclassification had no impact on previously reported total revenues.
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates
The preparation of the consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions in the Company’s consolidated financial statements. These estimates are based on information available as of the date of the consolidated financial statements. Such management estimates and assumptions include, but are not limited to the determination of:
the standalone selling price (“SSP”) of performance obligations for revenue contracts with multiple performance obligations;
the recognition, measurement and valuation of current and deferred income taxes and uncertain tax positions.
Actual results could differ materially from these estimates.
Segment
The Company operates as a single operating segment and derives revenue primarily from fees earned from subscription-based arrangements for providing customers software in a cloud-based-infrastructure that the Company provides, and from the sale of on-premises term license agreements.
An operating segment is defined as a component of an entity for which discrete financial information is available and whose results of operations are regularly reviewed by the chief operating decision maker (“CODM”). Effective August 31, 2024. Scott Farquhar stepped down from his role as Co-CEO, at that time, Mike Cannon-Brookes became the sole CEO, and in conjunction with that change, became the sole CODM. The CODM manages the Company using consolidated financial information. Further, the Company offers a connected portfolio of apps that are built on a single Atlassian platform and data model. Accordingly, the Company has determined it operates as a single operating and reportable segment.
The CODM uses consolidated net loss to allocate resources, including headcount, and make business investment decisions during the Company’s budgeting process. The CODM also uses consolidated net loss to assess performance by comparing the consolidated results to forecasts. Significant segment expenses are organized by function and are presented on the Consolidated Statements of Operations. Other segment items included in consolidated net loss are: other income and expense, net, interest income, interest expense and the provision for income taxes, which are reflected in the Consolidated Statements of Operations.
Foreign Currency
The Company’s consolidated financial statements are presented using the U.S. dollar, which is its reporting currency. The functional currency for certain of the Company’s foreign subsidiaries is the U.S. dollar, while others use local currencies. The Company translates the foreign functional currency financial statements to U.S. dollars for those entities that do not have the U.S. dollar as their functional currency using the exchange rates at the balance sheet date for assets and liabilities, the period average exchange rates for revenues and expenses, and the historical exchange rates for equity transactions. The effects of foreign currency translation adjustments are recorded in accumulated other comprehensive income in the Consolidated Statements of Comprehensive Income (Loss). Foreign currency transaction gains and losses are included in other income (expense), net on the Consolidated Statements of Operations.
Revenue from Contracts with Customers
Policies, Estimates and Judgments
Revenues are generally recognized upon the transfer of control of promised products or services provided to customers, reflecting the amount of consideration the Company expects to receive for those products or services. The Company enters into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. Revenue is recognized net of sales and other similar taxes collected from customers, which are subsequently remitted to governmental authorities.
Revenues are recognized upon the application of the following steps:
Identification of the contract or contracts with a customer;
Identification of the performance obligations in the contract;
Determination of the transaction price;
Allocation of the transaction price to the performance obligations in the contract; and
Recognition of revenue when, or as, the performance obligation is satisfied.
The timing of revenue recognition may differ from the timing of billing to its customers. The Company receives payments from customers based on a billing schedule as established in its contracts. Contract assets are recognized when performance is completed in advance of billings. Deferred revenue is recorded when billings are in advance of performance under the contract. The Company’s revenue arrangements include standard warranty provisions that the products and services will perform and operate in all material respects with the applicable published specifications, the financial impacts of which have historically been and are expected to continue to be insignificant. The Company’s contracts do not include a significant financing component.
Customer contracts often include promises to transfer multiple products and services to a customer.
The Company allocates the transaction price for each customer contract to each performance obligation based on the relative SSP for each distinct performance obligation. Judgment is required in determining the SSP for each distinct performance obligation. The Company typically determines an SSP range for its products and services, which is reassessed on a periodic basis or when facts and circumstances change. In most cases, the Company is able to determine SSP based on the observable prices of products or services sold separately. In instances where performance obligations do not have observable standalone sales, the Company utilizes available information that may include market conditions, pricing strategies, the life of the software, and other observable inputs to estimate the price that it would charge if the products and services were sold separately.
Recognition of Revenue
Revenue recognized from contracts with customers is disaggregated into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. The Company reports revenues in two categories: (i) subscription, (ii) other. In addition, revenue is presented by geographic region and deployment option in Note 12, “Revenue.”
Subscription Revenues
Subscription revenues consist primarily of fees earned from subscription-based arrangements for providing customers the right to use the Company’s software in a cloud-based-infrastructure that the Company provides (“Cloud offerings”). The Company also sells on-premises term license agreements for its Data Center products (“Data Center offerings”), consisting of software licensed for a specified period and support and maintenance services that are bundled with the license for the term of the license period. Subscription revenues are driven primarily by the number and size of active licenses, the type of product and the price of the licenses. Subscription-based arrangements generally have a contractual term ofone totwelve months. For Cloud offerings, subscription revenue is recognized ratably as services are delivered, commencing with the date the service is made available to customers. For Data Center offerings, the Company recognizes revenue upfront for the portion that relates to the delivery of the term license and the support revenue is recognized ratably as the services are delivered over the term of the arrangement. The revenue recognition policy is consistent for subscription sales generated directly with customers and sales generated indirectly through solution partners and resellers.
Other Revenues
Other revenues primarily include fees received for sales of third-party apps in the Atlassian Marketplace. Advisory services and training services are also included in other revenues. Revenue from the sale of third-party apps via the Atlassian Marketplace is recognized on the date of product delivery given that all of the Company’s obligations have been met at that time and on a net basis as the Company functions as the agent in the relationship. Revenue from advisory services is recognized over the time period that the customer has access to the service. Revenue from advisory and training is recognized over time as the services are performed. Maintenance revenue related to the Company’s Server offerings is immaterial after the Server end of support date and has been classified in other revenues within its Consolidated Statements of Operations for all periods presented.
Deferred Contract Acquisition Costs
Deferred contract acquisition costs are costs incurred to obtain a contract, if such costs are recoverable, and consist primarily of sales commissions and related payroll taxes. Incremental costs of obtaining a contract are earned on new and expansion contracts which are capitalized and amortized over the average period of benefit, which the Company estimates to befour years. The Company does not pay sales commissions upon contract renewal.
The Company determines the period of benefit for commissions paid for the acquisition of the customer contract by taking into consideration the initial estimated customer life, anticipated renewals, and the technological life of its software. The Company includes the deferred contract costs in prepaid expense and other current assets and other non-current assets on the Consolidated Balance Sheets and the amortization of deferred contract acquisition costs in marketing and sales expense on the Consolidated Statements of Operations.
Cash, Cash Equivalents and Restricted Cash
Cash and cash equivalents consist of highly liquid investments with an original maturity of three months or less at the date of purchase. Cash equivalents also include amounts due from third-party credit card processors as they are both short-term and highly liquid in nature and are typically converted to cash within three days of the sales transaction. Cash and cash equivalents are stated at fair value.
As of June 30, 2025 and 2024, the Company had restricted cash of $0.9 million and $1.2 million, respectively, primarily used for the benefit of employees through a deferred compensation plan, and such amounts were not available for use in the Company’s operations. Restricted cash is included in other non-current assets in the Consolidated Balance Sheets.
Accounts Receivable, net
The Company records trade accounts receivable at the invoice value, and such receivables are non-interest bearing. The Company considers receivables past due based on the contractual payment terms. The Company makes estimates of expected credit and collectability trends based on an assessment of various factors including historical credit loss experience, adjusted for forward-looking factors specific to the debtors and the economic environment that may affect the Company’s ability to collect from customers. The allowance for credit losses and write offs were not material for each of the periods ended June 30, 2025, 2024 and 2023.
Fair Value Measurements
Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy prioritizes the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories of inputs:
Level 1 - Quoted (unadjusted) market prices in active markets for identical assets or liabilities;
Level 2 - Observable inputs (other than Level 1 prices) such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities;
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or examination.
Marketable Securities
The Company classifies all marketable debt securities that have original stated maturities of greater than three months as marketable securities on its Consolidated Balance Sheets. The Company determines the appropriate classification of its investments in marketable debt securities at the time of purchase and reevaluates such designation at each balance sheet date. The Company has classified and accounted for its marketable debt securities as available-for-sale (“AFS”). After consideration of its risk versus reward objectives, as well as its liquidity requirements, the Company may sell these debt securities prior to their stated maturities. The Company considers all of its marketable securities as funds available for use in current operations, including those with maturity dates beyond one year, and therefore classifies these securities as current assets on the Consolidated Balance Sheets.
The Company evaluates AFS securities with unrealized loss positions for credit loss by assessing whether the decline in fair value below the amortized cost basis has resulted from a credit loss or other factors, whether the Company expects to recover the entire amortized cost basis of the security, its intent to sell and whether it is more likely than not that the Company will be required to sell the securities before the recovery of their amortized cost basis. The Company carries these securities at fair value, and reports the unrealized gains and losses, net of taxes, as a component of accumulated other comprehensive income except for the changes in allowance for expected credit losses, which are recorded in other income (expense), net. Realized gains and losses are determined based on the specific identification method and are reported in other income (expense), net on the Consolidated Statements of Operations.
Strategic Investments
The Company holds strategic investments in privately held debt and equity securities. Investments in privately held debt securities are classified as AFS securities. Investments in privately held equity securities without readily determinable fair values in which the Company does not own a controlling interest or have significant influence over are measured in accordance with the measurement alternative. In applying the measurement alternative, the carrying value of the investment is measured at cost, less impairment, if any, plus or minus changes resulting from observable price changes from orderly transactions for the identical or a similar investment of the same issuer in the period of occurrence. Changes to the carrying value of these investments are recorded through other income (expense), net on the Consolidated Statements of Operations.
In determining adjustments to the carrying value of its strategic invest ments in privately held companies, the Company uses the most recent data available to the Company. Valuations of privately held securities are inherently complex and the determination of whether an orderly transaction is for an identical or similar investment requires judgment. In its evaluation, the Company considers factors such as differences in the rights and preferences of the investments and the extent to which those differences would affect the fair values of those investments. The Company’s impairment analysis encompasses an assessment of both qualitative and quantitative factors, including the investee’s financial metrics, market acceptance of the investee’s product or technology, general market conditions, and liquidity considerations.
Equity Method Investments
Privately held equity securities in which the Company does not have a controlling financial interest but does exercise significant influence over the investment are accounted for under the equity method. The Company records a proportionate share of the investment’s earnings or losses, and impairment, if any, as a component of other income (expense), net in the Consolidated Statements of Operations. These investments are included in strategic investments in the Consolidated Balance Sheets.
For entities that meet the definition of a variable interest entity (“VIE”), the Company consolidates those entities when the Company is the primary beneficiary of the entity. The Company is determined to be the primary beneficiary when it possesses both the unilateral power to direct activities that most significantly impact the economic performance of the VIE and the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE. The Company continually evaluates whether it qualifies as the primary beneficiary and reconsiders its determination of whether an entity is a VIE upon reconsideration events. As of June 30, 2025, the Company has one investment in an unconsolidated VIE for which it exercises significant influence over their operations and accordingly accounts for it as an equity method investment.
Derivative Financial Instruments
The Company enters into foreign exchange forward contracts with the objective to mitigate certain currency risks associated with cost of revenues and operating expenses denominated in foreign currencies. These foreign exchange forward contracts are designated as cash flow hedges. The Company also enters into foreign exchange forward contracts to hedge a portion of certain foreign currency denominated as monetary assets and liabilities to reduce the risk that such foreign currency will be adversely affected by changes in exchange rates. The Company does not enter into derivative instrument transactions for trading or speculative purposes.
Hedging derivative instruments are recognized as either assets or liabilities and are measured at fair value. For derivative instruments designated as cash flow hedges, the gains (losses) on the derivatives are initially reported as a component of other comprehensive income and are subsequently recognized in earnings when the hedged exposure is recognized in earnings. For derivative instruments that are not designated as hedges, gains (losses) from changes in fair values are primarily recognized in other income (expense), net. The Company enters into master netting agreements with financial institutions to execute its hedging program. The master netting agreements are with select financial institutions to reduce the Company’s credit risk, as well as to reduce its concentration of risk with any single counterparty.
Property and Equipment
Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method to allocate the cost over the estimated useful lives. The estimated useful lives for each asset class are as follows:
| Equipment | 3 years |
|---|---|
| Computer hardware and computer-related software | 3 years |
| Furniture and fittings | 5 years |
| Leasehold improvements | Shorter of the remaining lease term or 7 years |
Leases
The Company determines if an arrangement is a lease at inception. The Company’s lease agreements generally contain lease and non-lease components. Payments under the Company’s lease arrangements are primarily fixed. Non-lease components primarily include payments for maintenance and utilities. The Company combines fixed payments for non-lease components with lease payments and accounts for them together as a single lease component, which increases the amount of its lease assets and liabilities.
Certain lease agreements contain variable payments, which are expensed as incurred and not included in the lease assets and liabilities. These amounts include payments affected by the Consumer Price Index and payments for maintenance and utilities.
Lease assets and liabilities are recognized at the present value of the future lease payments at the lease commencement date. The interest rate used to determine the present value of the future lease payments is the Company’s incremental borrowing rate, because the interest rate implicit in the Company’s leases is not readily determinable. The Company’s incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in economic environments where the leased asset is located. The Company’s lease terms include periods under options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The Company generally uses the base, non-cancelable, lease term when determining the lease assets and liabilities. The Company reassesses the lease term if and when a significant event or change in circumstances occurs. Lease assets also include any prepaid lease payments and lease incentives. Operating lease expense (excluding variable lease costs) is recognized on a straight-line basis over the lease term.
The Company applies the short-term lease recognition exemption for short-term leases, which are leases with a lease term of 12 months or less. Payments associated with short-term leases are recognized on a straight-line basis over the lease term.
The Company did not have any finance lease arrangements for fiscal years 2025, 2024, and 2023.
Business Combinations
The Company allocates the purchase price of acquired companies to the tangible and intangible assets acquired and liabilities assumed, based on their estimated fair values. The excess of the purchase price over the fair values of these identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred.
The Company uses its best estimates and assumptions to assign fair value to the tangible and intangible assets acquired and liabilities assumed at the acquisition date. Assumptions used to estimate the fair value of the intangible assets include, but are not limited to, projected revenue growth, projected operating expenses, and technology migration curves. These estimates are inherently uncertain and subject to refinement and, as a result, actual results may differ from estimates.
During the measurement period, which may not be later than one year from the acquisition date, the Company may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the Consolidated Statements of Operations.
Intangible Assets
The Company acquires intangible assets separately or in connection with business combinations. Intangible assets are measured at cost initially. Intangible assets with finite lives are amortized over their estimated useful life using the straight-line method. The amortization expense on intangible assets is recognized in the Consolidated Statements of Operations in the expense category consistent with the function of the intangible asset.
The estimated useful lives for each intangible asset class are as follows:
| Patents, trademarks, and other rights | 5 - 12 years |
|---|---|
| Customer relationships | 5 - 10 years |
| Acquired developed technology | 4 - 7 years |
Impairment of Long-Lived Assets
Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate an asset’s carrying value may not be recoverable. When the projected undiscounted cash flows estimated to be generated by those assets are less than their carrying amounts, the assets are adjusted to their estimated fair value and an impairment loss is recorded as a component of operating income (expense).
Goodwill
Goodwill is the excess of the aggregate of the consideration transferred over the identifiable assets acquired and liabilities assumed.
Goodwill is tested for impairment at least annually during the fourth quarter of the Company’s fiscal year and more often if and when circumstances indicate that the carrying value may be impaired. The Company’s reporting unit is at the operating segment level. The Company performs its goodwill impairment test at the level of its operating segment, as there are no levels below the operating segment level for which discrete financial information is prepared and regularly reviewed by the Company’s CODM. A qualitative assessment is performed to determine whether it is more likely than not that the fair value of its operating segment is less than its carrying amount. If the operating segment does not pass the qualitative assessment, the carrying amount of the operating segment, including goodwill, is compared to fair value and goodwill is considered impaired if the carrying value exceeds its fair value. Any excess is recognized as an impairment loss in the current period earnings.
Stock-based Compensation
The Company recognizes compensation expense related to all stock-based awards, including restricted stock units (“RSU”) and restricted stock awards (“RSA”) issued to the Company’s employees in exchange for their service, based on the estimated fair value of the awards on the grant date. The fair value of each RSU or RSA is based on the fair value of the Company’s Class A Common Stock on the date of grant.
The Company recognizes costs related to stock-based awards, net of estimated forfeitures, over the awards’ requisite service period on a straight-line basis, which is generally four years. The Company estimates forfeitures based on historical experience. The respective expenses are recognized as employee benefits and classified in the Consolidated Statements of Operations according to the activities that the employees perform.
Defined Contribution Plan
The Company offers various defined contribution plans for its U.S. and non-U.S. employees. The Company matches a portion of employee contributions each pay period, subject to maximum aggregate matching amounts, or contributes based on local legislative rates for eligible employees. Total defined contribution plan expense was $114.5 million, $96.3 million, and $78.2 million for fiscal years 2025, 2024, and 2023, respectively.
Advertising Costs
Advertising costs are expensed as incurred as a component of marketing and sales expense in the Consolidated Statements of Operations. Advertising expense was $153.1 million, $100.2 million, and $89.5 million for fiscal years 2025, 2024, and 2023, respectively.
Research and development costs are expensed as incurred and consist of the employee, software, and hardware costs incurred for the development of new apps, AI agents and products, enhancements and updates of existing offerings and quality assurance activities. The costs incurred for the development of the Company’s cloud-based platform and internal use software are evaluated for capitalization during the development phase. Capitalized software development costs on the Company’s Consolidated Balance Sheet were not material for the periods presented.
Concentration of Credit Risk and Significant Customers
Financial instruments potentially exposing the Company to credit risk consist primarily of cash, cash equivalents, accounts receivable, derivative contracts and investments. The Company holds cash at financial institutions that management believes are high credit, quality financial institutions and invests in investment grade securities rated A- and above and debt securities. The Company’s derivative contracts expose it to credit risk to the extent that the counterparties may be unable to meet the terms of the arrangement. The Company enters into master netting agreements with select financial institutions to reduce its credit risk and trades with several counterparties to reduce its concentration risk with any single counterparty. The Company does not have significant exposure to counterparty credit risk at this time. In addition, the Company does not require nor is required to post collateral of any kind related to any foreign currency derivatives.
Credit risk arising from accounts receivable is mitigated to a certain extent due to the Company’s large number of customers and their dispersion across various industries and geographies. The Company’s customer base is highly diversified, thereby limiting credit risk. The Company manages credit risk with customers by closely monitoring its receivables and contract assets. The Company continuously monitors outstanding receivables locally to assess whether there is objective evidence that outstanding accounts receivables and contract assets are credit-impaired. As of June 30, 2025 and June 30, 2024, no customer represented more than 10% of the total accounts receivable balance. For fiscal years ended June 30, 2025, 2024, and 2023, no customer represented more than 10% of the total revenues.
The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred income tax assets and liabilities represent temporary differences between the carrying amounts of assets and liabilities in the consolidated financial statements and their corresponding tax basis used in the computation of taxable income. The Company measures deferred tax assets and liabilities using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be reversed. The Company recognizes the effect on deferred tax assets and liabilities of a change in tax rates within the provision for income taxes as expense and income in the period that includes the enactment date. The Company accounts for the tax impact of including Global Intangible Low-Taxed Income in U.S. taxable income as a period cost. A valuation allowance is established if it is more likely than not that all or a portion of the deferred tax asset will not be realized.
Changes in deferred tax assets or liabilities are recognized as a component of benefit from (provision for) income taxes in the Consolidated Statements of Operations, except where they relate to items that are recognized in other comprehensive income or directly in equity, in which case the related deferred tax is also recognized in other comprehensive income or equity, respectively. Where deferred tax arises from the initial accounting for a business combination, the tax effect is included in the accounting for the business combination.
Deferred tax assets are regularly evaluated for future realization and reduced by a valuation allowance to an amount for which realization is more likely than not. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing temporary differences, projected future taxable income, tax planning strategies, carry back potential if permitted under the tax law, and results of recent operations. Significant management judgment is required to determine the amount of deferred tax assets that can be recognized, based upon the likely timing and the amount of future taxable income, together with future tax-planning strategies. Assumptions about the generation of future taxable income depend on management’s estimates of future cash flows, future business expectations, capital expenditures, dividends, and other capital management transactions. Management judgment is also required in relation to the application of income tax legislation, which involves complexity and an element of uncertainty. In the event there is a change in the Company’s assessment of its ability to recover deferred tax assets, the income tax provision would be adjusted accordingly, resulting in a corresponding adjustment to the Consolidated Statements of Operations.
Uncertain tax positions are recorded in accordance with Accounting Standards Codification Topic 740 Income Taxes (“ASC 740”), Income Taxes. ASC 740 specifies a two-step process in which (1) the Company determines whether it’s more likely than not that tax positions will be sustained on the basis of the technical merits of the position, and (2) for those positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more likely than not to be realized upon ultimate settlement with the related tax authority. The Company considers many factors when evaluating uncertain tax positions, which involve significant judgment and may require periodic reassessment. The Company recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense. For details of taxation, please refer to Note 16, “Income Taxes.”
New Accounting Standards Not Yet Adopted in Fiscal Year 2025
In December 2023, the FASB issued Accounting Standards Update (“ASU”) No. 2023-09“Income Taxes (Topic 740): Improvements to Income Tax Disclosures.”This ASU requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. This ASU is effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the impact of the new guidance and does not expect it to have a material impact on its consolidated financial statements.
In November 2024, the FASB issued ASU No. 2024-03“Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures.”This ASU requires disaggregated disclosure of income statement expenses for public entities. The ASU does not change the expense captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. This ASU is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements.
In July 2025, the FASB issued ASU 2025-05 “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets for Private Companies and Certain Not-for-Profit Entities,” which amends ASC 326-20 to provide a practical expedient and an accounting policy election (for all entities, other than public business entities that elect the practical expedient) related to the estimation of expected credit losses for current accounts receivable and current contract assets that arise from transactions accounted for under ASC 606. This ASU is effective for fiscal years beginning after December 15, 2025, and early adoption is permitted. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements.
Recently Adopted Accounting Pronouncements
In November 2023, the FASB issued ASU No. 2023-07“Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” This ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. All disclosure requirements under ASU 2023-07 are also required for public entities with a single reportable segment. This ASU is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024 with early adoption permitted and requires retrospective application to all prior periods. The Company adopted ASU 2023-07 for the year ended June 30, 2025. The adoption of the standard did not result in significant change to the Company’s consolidated financial statement disclosures. Refer to the Segment section of Note 2, “Summary of Significant Accounting Policies”for further information.
- Fair Value Measurements
The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2025, by level within the fair value hierarchy (in thousands):
| Level 1 | Level 2 | Total | |
|---|---|---|---|
| Assets measured at fair value | |||
| Cash and cash equivalents: | |||
| Money market funds | $1,774,138 | $— | $1,774,138 |
| Corporate debt securities | — | 382 | 382 |
| Marketable securities: | |||
| U.S. treasury securities | — | 176,661 | 176,661 |
| Agency securities | — | 3,216 | 3,216 |
| Certificates of deposit and time deposits | — | 10,000 | 10,000 |
| Commercial paper | — | 19,697 | 19,697 |
| Corporate debt securities | — | 214,694 | 214,694 |
| Derivative financial instruments | — | 23,234 | 23,234 |
| Total assets measured at fair value | $1,774,138 | $447,884 | $2,222,022 |
| Liabilities measured at fair value | |||
| Derivative financial instruments | $— | $2,445 | $2,445 |
| Total liabilities measured at fair value | $— | $2,445 | $2,445 |
The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2024, by level within the fair value hierarchy (in thousands):
| Level 1 | Level 2 | Total | |
|---|---|---|---|
| Assets measured at fair value | |||
| Cash and cash equivalents: | |||
| Money market funds | $1,563,234 | $— | $1,563,234 |
| Marketable securities: | |||
| U.S. treasury securities | — | 52,517 | 52,517 |
| Agency securities | — | 3,199 | 3,199 |
| Certificates of deposit and time deposits | — | 10,000 | 10,000 |
| Commercial paper | — | 20,010 | 20,010 |
| Corporate debt securities | — | 76,247 | 76,247 |
| Derivative financial instruments | — | 9,292 | 9,292 |
| Total assets measured at fair value | $1,563,234 | $171,265 | $1,734,499 |
| Liabilities measured at fair value | |||
| Derivative financial instruments | $— | $1,701 | $1,701 |
| Total liabilities measured at fair value | $— | $1,701 | $1,701 |
Due to the short-term nature of accounts receivables, net, contract assets, accounts payable, accrued expenses, and other current liabilities, their carrying amount is assumed to approximate their fair value.
Determination of Fair Value
The Company uses quoted prices in active markets for identical assets to determine the fair value of the Company’s Level 1 investments. The fair value of the Company’s Level 2 investments is determined based on quoted market prices or alternative market observable inputs.
Strategic Investments Measured and Recorded at Fair Value on a Non-Recurring Basis
The Company’s investments in privately held companies are not included in the tables above and are discussed in Note 4, “Investments.” The carrying value of the Company’s privately held equity securities are adjusted on a non-recurring basis upon observable price changes in orderly transactions for identical or similar investments of the same issuer, or impairment (referred to as the measurement alternative). Privately held equity securities that have been remeasured during the period based on observable price changes in orderly transactions are classified within Level 2 or Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods which may include a combination of the observable transaction price at the transaction date and other unobservable inputs including volatility, rights and preferences of the investments, and obligations of the securities the Company holds. The fair value of privately held equity securities that have been remeasured due to impairment are classified within Level 3. The Company’s privately held debt and equity securities amounted to $168.8 million and $148.7 million as of June 30, 2025 and June 30, 2024, respectively.
- Investments
Marketable Securities
The Company’s investments of marketable securities as of June 30, 2025, consisted of the following (in thousands):
| Amortized Cost | Unrealized Gains | Unrealized Losses | Fair Value | |
|---|---|---|---|---|
| Marketable securities | ||||
| U.S. treasury securities | $176,338 | $388 | $(65) | $176,661 |
| Agency securities | 3,197 | 19 | — | $3,216 |
| Certificates of deposit and time deposits | 10,000 | — | — | $10,000 |
| Commercial paper | 19,697 | — | — | $19,697 |
| Corporate debt securities | 214,190 | 527 | (23) | $214,694 |
| Total marketable securities | $423,422 | $934 | $(88) | $424,268 |
The Company’s investments of marketable securities as of June 30, 2024, consisted of the following (in thousands):
| Amortized Cost | Unrealized Gains | Unrealized Losses | Fair Value | |
|---|---|---|---|---|
| Marketable debt securities | ||||
| U.S. treasury securities | $52,570 | $30 | $(83) | $52,517 |
| Agency securities | 3,194 | 5 | — | 3,199 |
| Certificates of deposit and time deposits | 10,000 | — | — | 10,000 |
| Commercial paper | 20,010 | — | — | 20,010 |
| Corporate debt securities | 76,386 | 7 | (146) | 76,247 |
| Total marketable securities | $162,160 | $42 | $(229) | $161,973 |
The table below summarizes the Company’s marketable securities by remaining contractual maturity (in thousands):
| June 30, 2025 | June 30, 2024 | |
|---|---|---|
| Due in one year or less | $271,923 | $101,543 |
| Due in one year through five years | 152,345 | 60,430 |
| Total marketable debt investments | $424,268 | $161,973 |
The Company regularly reviews the changes to the rating of its marketable securities by rating agencies and monitors the surrounding economic conditions to assess the risk of expected credit losses. As of June 30, 2025 and 2024, unrealized losses and the related risk of expected credit losses were not material.
Strategic Investments
Carrying value of privately held debt securities
The Company’s investments of privately held debt securities as of June 30, 2025, consisted of the following (in thousands):
| Amortized Cost | Unrealized Gains | Unrealized Losses | Fair Value | |
|---|---|---|---|---|
| Privately held debt securities | $7,780 | $— | $(3,350) | $4,430 |
The Company’s investments of privately held debt securities as of June 30, 2024, consisted of the following (in thousands):
| Amortized Cost | Unrealized Gains | Unrealized Losses | Fair Value | |
|---|---|---|---|---|
| Privately held debt securities | $6,800 | $— | $(3,350) | $3,450 |
Carrying value of privately held equity securities
Privately held equity securities are measured using the measurement alternative. The carrying value is measured as the total initial cost plus the cumulative net gain (loss).
The carrying values of privately held equity securities as of June 30, 2025 are summarized below (in thousands):
| Privately held equity securities | |
|---|---|
| Initial total cost | $166,302 |
| Cumulative net losses | (1,909) |
| Carrying value | $164,393 |
Privately held equity securities’ cumulative net losses were comprised of downward adjustments and impairment of $8.5 million and upward adjustments of $6.6 million as of June 30, 2025.
The carrying values of privately held equity securitiesas of June 30, 2024 are summarized below (in thousands):
| Privately held equity securities | |
|---|---|
| Initial total cost | $147,752 |
| Cumulative net losses | (2,491) |
| Carrying value | $145,261 |
Privately held equity securities’ cumulative net losses were comprised of downward adjustments and impairment of $7.5 million and upward adjustments of $5.0 million as of June 30, 2024.
Gains and Losses on Strategic Investments
The components of gains and losses on strategic investments were as follows (in thousands):
| Fiscal Year Ended June 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Unrealized losses recognized on publicly traded equity securities | $— | $— | $(11,437) |
| Unrealized gains recognized on privately held equity securities | 1,549 | 2,084 | 307 |
| Unrealized losses recognized on privately held equity securities including impairment | (967) | (1,628) | (7,642) |
| Unrealized losses on privately held debt securities | — | (500) | (350) |
| Unrealized gains (losses), net | $582 | $(44) | $(19,122) |
| Realized gains recognized on publicly traded equity securities | — | 515 | — |
| Realized losses recognized on privately held equity securities | (3,142) | (2,546) | — |
| Realized losses on privately held debt securities | — | — | (285) |
| Losses on strategic investments, net | $(2,560) | $(2,075) | $(19,407) |
| Unrealized gains (losses) recognized during the reporting period on privately held equity securities still held at the reporting date | $582 | $456 | $(6,986) |
Unrealized gains recognized on privately held equity securities include upward adjustments from equity securities accounted for under the measurement alternative, while unrealized losses recognized on privately held equity securities includes downward adjustments and impairment.
Realized gains on sales of securities, net, reflect the difference between the sale proceeds and the carrying value of the security at the beginning of the period or the purchase date, if later.
Equity Method Investment
Vertical First Trust (“VFT”) was established for the construction project associated with the Company’s new global headquarters in Sydney, Australia (the “Australian HQ Property”). In fiscal year 2023, the Company completed a non-cash sale of the controlling interest of VFT to a third-party buyer as part of the contemplated transactions for the buyer to invest in and develop the Australian HQ Property. As of the date of sale, the Company used a discounted cash flow model to calculate the fair value of its retained equity interest. The fair value of the retained interest at the date of sale was $88.9 million, and is classified as a Level 3 investment in the fair value hierarchy. The inputs to the valuation included observable inputs, including capitalization rate, discount rate, and other management inputs, including the underlying building’s practical completion date. The maximum exposure to loss related to the Company’s investment in VFT equals the Company’s capital investment.
The Company retained a minority equity interest of 13% in the form of ordinary units in VFT and has significant influence in VFT. The Company’s interest in VFT is accounted for using the equity method in the consolidated financial statements. Under the equity method, the Company records its proportionate share of VFT’s earnings or losses.
The following table sets forth the carrying amounts of the equity method investment and the movements during fiscal years 2024 and 2025 (in thousands):
| Equity Method Investment | |
|---|---|
| Balance as of June 30, 2023 | $85,436 |
| Share of losses | (11,262) |
| Effect of change in exchange rates | 336 |
| Balance as of June 30, 2024 | $74,510 |
| Share of losses | (20,433) |
| Effect of change in exchange rates | (958) |
| Balance as of June 30, 2025 | $53,119 |
The carrying amount of the Company’s investment in VFT was reported within strategic investments in the Company’s Consolidated Balance Sheets.
- Derivative Contracts
The Company has derivative instruments that are used for hedging activities as discussed below.
The following table sets forth the notional amounts of the Company’s hedging derivative instruments as of June 30, 2025 (in thousands):
| Notional Amounts of Derivative Instruments | ||||||
|---|---|---|---|---|---|---|
| Notional Amount by Term to Maturity · Classification by Notional Amount | ||||||
| Under 12 months | Over 12 months | Total | Cash Flow Hedge | Non Hedge | Total | |
| Forward contracts | $1,064,280 | $79,858 | $1,144,138 | $765,613 | $378,525 | $1,144,138 |
The following table sets forth the notional amounts of the Company’s hedging derivative instruments as of June 30, 2024 (in thousands):
| Notional Amounts of Derivative Instruments | ||||||
|---|---|---|---|---|---|---|
| Notional Amount by Term to Maturity · Classification by Notional Amount | ||||||
| Under 12 months | Over 12 months | Total | Cash Flow Hedge | Non Hedge | Total | |
| Forward contracts | $837,182 | $71,701 | $908,883 | $651,303 | $257,580 | $908,883 |
During fiscal year 2024, the Company settled its then existing interest rate swap contracts prior to their stated termination dates as a result of the repayment of the Term Loan (defined in Note 10, “Debt.”) and received cash proceeds of $37.7 million from the counterparties. The cash proceeds are reported within net cash provided by operating activities in the Company’s Consolidated Statements of Cash Flowsin fiscal year 2024. Gains resulting from the early termination of interest rate swap contracts were deferred and amortized as adjustments to interest expense over the remaining period of the debt originally covered by the terminated swap contracts.
The fair value of the Company’s derivative instruments were as follows (in thousands):
| As of June 30, | |||
|---|---|---|---|
| Balance Sheet Location | 2025 | 2024 | |
| Derivative assets | |||
| Derivatives designated as hedging instruments: | |||
| Foreign exchange forward contracts | Prepaid expenses and other current assets | $16,210 | $8,255 |
| Foreign exchange forward contracts | Other non-current assets | 3,715 | 867 |
| Derivatives not designated as hedging instruments: | |||
| Foreign exchange forward contracts | Prepaid expenses and other current assets | 3,309 | 170 |
| Total derivative assets | $23,234 | $9,292 | |
| Derivative liabilities | |||
| Derivatives designated as hedging instruments: | |||
| Foreign exchange forward contracts | Accrued expenses and other current liabilities | $2,409 | $1,197 |
| Foreign exchange forward contracts | Other non-current liabilities | — | 7 |
| Derivatives not designated as hedging instruments: | |||
| Foreign exchange forward contracts | Accrued expenses and other current liabilities | 36 | 497 |
| Total derivative liabilities | $2,445 | $1,701 | |
The pre-tax effects of derivatives designated as cash flow hedging instruments on the consolidated financial statements were as follows (in thousands):
| Fiscal Year Ended June 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Beginning balance of accumulated gains (losses) in accumulated other comprehensive income | $41,424 | $48,170 | $24,502 |
| Gross unrealized gains (losses) recognized in other comprehensive income (loss) | (1,897) | 10,826 | 17,952 |
| Net losses (gains) reclassified from cash flow hedge in accumulated other comprehensive income (loss) into profit or loss: | |||
| Recognized in cost of revenues | 1,447 | 1,072 | 1,831 |
| Recognized in research and development | 7,194 | 7,718 | 16,890 |
| Recognized in marketing and sales | 1,027 | 1,264 | 1,337 |
| Recognized in general and administrative | 1,828 | 2,320 | 5,563 |
| Recognized in interest | (26,344) | (29,946) | (19,905) |
| Ending balance of accumulated gains in accumulated other comprehensive income (loss) | $24,679 | $41,424 | $48,170 |
- Property and Equipment
Property and equipment, net consisted of the following (in thousands):
| As of June 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Equipment | $15,008 | $11,200 |
| Computer hardware and software | 58,559 | 40,824 |
| Furniture and fittings | 25,217 | 25,172 |
| Leasehold improvements and other | 154,113 | 129,575 |
| Property and equipment, gross | 252,897 | 206,771 |
| Less: accumulated depreciation | (147,779) | (120,456) |
| Property and equipment, net | $105,118 | $86,315 |
Depreciation expense was $36.9 million, $29.0 million, and $27.8 million for fiscal years 2025, 2024, and 2023, respectively. During fiscal year 2023, the Company recorded an $8.4 million impairment charge to leasehold improvements as a result of the Company’s restructuring efforts, this charge is shown as a reduction of the gross cost.
- Goodwill and Intangible Assets
Goodwill
Goodwill represents the excess of the purchase price in a business combination over the fair value of net tangible and intangible assets acquired. Goodwill amounts are not amortized but rather tested for impairment at least annually during the fourth quarter, or when indicators of impairment exist.
Goodwill consisted of the following (in thousands):
| Goodwill | |
|---|---|
| Balance as of June 30, 2023 | $727,211 |
| Additions | 561,372 |
| Effect of change in exchange rates | 173 |
| Balance as of June 30, 2024 | 1,288,756 |
| Additions | 14,022 |
| Effect of change in exchange rates | 1,667 |
| Balance as of June 30, 2025 | $1,304,445 |
During fiscal year 2025, the Company completed two acquisitions to expand the Company’s product and service offerings. These transactions were accounted for as business combinations and were not material individually or collectively to the consolidated financial statements.
Intangible Assets
Intangible assets consisted of the following as of June 30, 2025 (in thousands):
| Gross Carrying Amount | Accumulated Amortization | Net | |
|---|---|---|---|
| Acquired developed technology | $466,932 | $(278,525) | $188,407 |
| Patents, trade names, and other rights | 70,928 | (37,337) | 33,591 |
| Customer relationships | 135,687 | (112,845) | 22,842 |
| Total Intangible Assets | $673,547 | $(428,707) | $244,840 |
Intangible assets consisted of the following as of June 30, 2024 (in thousands):
| Gross Carrying Amount | Accumulated Amortization | Net | |
|---|---|---|---|
| Acquired developed technology | $469,752 | $(242,137) | $227,615 |
| Patents, trade names, and other rights | 70,928 | (31,427) | 39,501 |
| Customer relationships | 135,687 | (103,746) | 31,941 |
| Total Intangible Assets | $676,367 | $(377,310) | $299,057 |
The weighted-average remaining useful lives of the Company’s acquired intangible assets as of June 30, 2025 are as follows:
| Weighted-Average Remaining Useful Lives (Years) | |
|---|---|
| Acquired developed technology | 5 |
| Patents, trade names, and other rights | 6 |
| Customer relationships | 3 |
Amortization expense for intangible assets was approximately $55.5 million, $49.7 million, and $33.1 million for fiscal years 2025, 2024, and 2023, respectively.
The following table presents the estimated future amortization expense related to intangible assets held as of June 30, 2025 (in thousands):
| Fiscal Years: | |
|---|---|
| 2026 | $53,030 |
| 2027 | 47,861 |
| 2028 | 45,634 |
| 2029 | 40,128 |
| 2030 | 37,708 |
| Thereafter | 20,479 |
| Total future amortization expense | $244,840 |
- Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consist of the following (in thousands):
| As of June 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Accrued expenses | $180,197 | $149,046 |
| Employee benefits | 422,986 | 332,518 |
| Tax liabilities | 36,726 | 55,203 |
| Customer deposits | 16,396 | 19,279 |
| Other payables | 25,296 | 21,313 |
| Total accrued expenses and other current liabilities | $681,601 | $577,359 |
- Leases
The Company rents office space and equipment under non-cancelable operating leases with various expiration dates through fiscal year 2034. Certain lease agreements include varying terms, escalation clauses and renewal rights. The Company does not assume renewals in its determination of the lease term unless the renewals are deemed to be reasonably certain at lease commencement. The Company’s lease agreements generally do not contain any material residual value guarantees or material restrictive covenants.
The components of lease costs and other information related to leases were as follows (in thousands):
| Fiscal Year Ended June 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Operating lease costs | $43,720 | $41,426 | $50,134 |
| Variable lease costs | 14,781 | 11,908 | 13,094 |
| Total lease costs | $58,501 | $53,334 | $63,228 |
| Weighted average remaining lease term (in years) | 5 | 6 | 7 |
| Weighted average discount rate | 3.1% | 2.9% | 2.5% |
Supplemental cash flow information related to operating leases were as follows (in thousands):
| Fiscal Year Ended June 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Cash payments for operating leases | $52,981 | $49,803 | $41,493 |
| Right-of-use assets obtained in exchange for new operating lease liabilities | $34,717 | $23,265 | $3,580 |
Future lease payments under non-cancelable operating leases with initial lease terms in excess of one year included in the Company’s lease liabilities as of June 30, 2025 were as follows (in thousands):
| Fiscal years: | Operating Lease Payments |
|---|---|
| 2026 | $57,056 |
| 2027 | 57,224 |
| 2028 | 56,667 |
| 2029 | 46,237 |
| 2030 | 16,188 |
| Thereafter | 38,743 |
| Total future operating lease payments | 272,115 |
| Less: imputed interest | (20,468) |
| Total lease liability balance | $251,647 |
During fiscal year 2023, in addition to operating lease costs disclosed above, the Company recorded an impairment charge of $52.7 million in aggregate for operating lease right-of-use assets as part of the Company’s lease consolidation efforts.
The Company entered into an Agreement for Lease (the “AFL”) for the Australian HQ Property in March 2022. Following the completion of the development of the Australian HQ Property, the AFL requires the Company to enter into a lease agreement for the planned headquarters office space. The lease is expected to commence in fiscal year 2027 and will continue forfifteen years, with the Company’s option to extend the term for up totwo additionalten-year periods. Future lease payments are approximately $912.3 million as of June 30, 2025, for the initial term offifteen years. Please refer to Note 4, “Investments,” for details of the transaction.
- Debt
Credit Facility
In August 2024, the Company’s principal U.S. operating subsidiary, Atlassian US, Inc., entered into an amended and restated credit agreement (the “2024 Credit Agreement”) which eliminated a term loan facility and provides for a $750 million senior unsecured revolving credit facility (the “2024 Credit Facility”). The 2024 Credit Agreement replaced the Company’s prior credit agreement entered into in October 2020 (“2020 Credit Agreement”) which provided for a $1 billion senior unsecured delayed-draw term loan facility (the “Term Loan”) and a $500 million senior unsecured revolving credit facility.
The 2024 Credit Facility bears interest, at the Company’s option, at a base rate or the Secured Overnight Financing Rate, plus, in each case, a spread of 0.875% to 1.50% per annum. In each case, the applicable margin will be determined by the consolidated leverage ratio of the Company and its subsidiaries, or, following the Company’s one time option, the Company’s credit rating. The Company may repay outstanding loans under the 2024 Credit Facility at any time, without premium or penalty, and the Company has the option to request an increase of $250 million in certain circumstances. The 2024 Credit Facility matures in August 2029. As of June 30, 2025, there were no borrowings under the 2024 Credit Facility.
The Company is also obligated to pay a commitment fee on the undrawn amounts of the 2024 Credit Facility at an annual rate ranging from 0.075% to 0.20%, determined by the Company’s consolidated leverage ratio, or, following the Company’s one time option, the Company’s credit rating.
The 2024 Credit Facility requires compliance with various financial and non-financial covenants, including affirmative and negative covenants. The financial covenants include a maximum consolidated leverage ratio of 3.5 x, which increases to 4.5 x during the period of four fiscal quarters immediately following a material acquisition. As of June 30, 2025, the Company was in compliance with all covenants associated with the 2024 Credit Facility.
Senior Notes
On May 15, 2024, the Company issued $500.0 million aggregate principal amount of 5.250% senior notes due 2029 (the “2029 Notes”) and $500.0 million aggregate principal amount of 5.500% senior notes due 2034 (the “2034 Notes,” and together with the 2029 Notes, the “Notes”). The Notes will mature on May 15, 2029, and May 15, 2034, respectively. The 2029 Notes bear interest at a rate of 5.250% per year. The 2034 Notes bear interest at a rate of 5.500% per year. Interest on the Notes is paid semi-annually in arrears on May 15 and November 15 of each year, beginning on November 15, 2024.
The Notes are senior unsecured obligations of the Company. The Company may redeem either series of the Notes, in whole or in part, at any time or from time to time at the applicable redemption price. Upon the occurrence of a change of control event, the Company will be required to make an offer to repurchase all outstanding notes from their holders at a price equal to 101% of their principal amount thereof, plus accrued and unpaid interest to, but not including, the date of repurchase. The indenture governing the Notes also includes covenants (including certain limited covenants restricting the Company’s ability to incur certain liens and enter into certain sale and leaseback transactions), events of default, and other customary provisions. As of June 30, 2025, the Company was in compliance with all covenants associated with the Notes.
The Company incurred debt discount and issuance costs of approximately $14.3 million in connection with the Notes offering, which were allocated on a pro rata basis to the 2029 Notes and 2034 Notes. The debt discount and issuance costs are amortized on an effective interest rate method to interest expense over the contractual term of the Notes. The proceeds from this offering, net of debt discounts and issuance costs, was $985.7 million. The net proceeds were used primarily to repay the Term Loan.
The carrying values of the Notes were as follows (in thousands, except percentage data):
| Instrument · Expected Remaining Term (years) · Contractual Interest Rate · Effective Interest Rate · June 30, 2025 · June 30, 2024 | |||||||
|---|---|---|---|---|---|---|---|
| 2029 Notes | 3.9 | 5.25% | 5.55% | $500,000 | $500,000 | ||
| 2034 Notes | 8.9 | 5.50% | 5.71% | 500,000 | 500,000 | ||
| Unamortized debt discount and issuance costs | (12,316) | (14,089) | |||||
| Long-term debt | $987,684 | $985,911 | |||||
As of June 30, 2025, the total estimated fair value of the Notes was approximately $1.0 billion. The estimated fair value of the Notes, which the Company deems Level 2 financial instruments, was determined based on quoted bid prices in an over-the-counter market on the last trading day of the reporting period.
- Commitments and Contingencies
Noncancellable Purchase Obligations
The Company has contractual commitments for services with third-parties related to its cloud services platform, marketing related contracts and other services. These commitments are non-cancellable and expire withintwo toseven years. There were no material contractual commitments that were entered into during fiscal year 2025 that were outside the ordinary course of business.
The following table sets forth contractual commitments as of June 30, 2025 and 2024 (in thousands):
| Fiscal Year Ended June 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Contractual purchase obligations | $1,814,106 | $1,415,724 |
| Obligations for leases that have not yet commenced | 912,344 | 964,825 |
| Total purchase obligation | $2,726,450 | $2,380,549 |
Maturities of purchase obligations as of June 30, 2025 were as follows (in thousands):
| Other contractualcommitments · Leases not commenced · Total | |||
|---|---|---|---|
| Fiscal Years: | |||
| 2026 | $473,895 | $— | $473,895 |
| 2027 | 516,731 | 26,579 | 543,310 |
| 2028 | 219,147 | 46,627 | 265,774 |
| 2029 | 79,333 | 48,492 | 127,825 |
| 2030 | 140,000 | 50,431 | 190,431 |
| Thereafter | 385,000 | 740,215 | 1,125,215 |
| Total commitments | $1,814,106 | $912,344 | $2,726,450 |
Please refer to Note 9, “Leases,” for discussion of lease commitments that the Company has entered but the leases have not yet commenced.
From time to time, the Company is party to litigation and other legal proceedings in the ordinary course of business. While the Company does not believe the ultimate resolutions of these pending legal matters are likely to have a material adverse effect on the Company’s financial position, the results of any litigation or other legal proceedings are uncertain and as such the resolution of such legal proceedings, either individually or in the aggregate, could have a material adverse effect on its business, results of operations, financial condition or cash flows. The Company accrues for loss contingencies when it is both probable that it will incur the loss and when it can reasonably estimate the amount of the loss or range of loss. For the periods presented, the Company has not recorded any liabilities as a result of the litigation or other legal proceedings in the consolidated financial statements.
Indemnification Provisions
The Company’s agreements include provisions indemnifying customers against intellectual property and other third-party claims. In addition, the Company has entered into indemnification agreements with its directors, executive officers, and certain other officers that will require the Company to, among other things, indemnify these individuals for certain liabilities that may arise as a result of their affiliation with the Company. For the periods presented, the Company has not incurred any costs as a result of such indemnification obligations and has not recorded any liabilities related to such obligations in the consolidated financial statements.
- Revenue
Remaining Performance Obligations
Transaction price allocated to the remaining performance obligations represents contracted revenue that has not yet been recognized, which includes deferred revenue and unbilled amounts that will be recognized as revenue in future periods. Transaction price allocated to the remaining performance obligations is influenced by several factors, including the timing of renewals, the timing of delivery of software licenses, average contract terms, and foreign currency exchange rates. Unbilled portions of the remaining performance obligations are subject to future economic, risks including bankruptcies, regulatory changes, and other market factors.
As of June 30, 2025, approximately $3.3 billion of revenue is expected to be recognized from transaction price allocated to remaining performance obligations. The Company expects to recognize revenue on approximately 74% of these remaining performance obligations over the next 12 months, with the balance recognized thereafter.
Disaggregated Revenue
The Company’s revenues by geographic region based on end-users who purchased the Company’s offerings are as follows (in thousands):
| Fiscal Year Ended June 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Americas | |||
| United States | $2,182,073 | $1,847,194 | $1,537,328 |
| Other Americas | 334,828 | 278,240 | 227,838 |
| Total Americas | 2,516,901 | 2,125,434 | 1,765,166 |
| EMEA | |||
| Germany | 539,550 | 442,063 | 330,046 |
| Other EMEA | 1,584,421 | 1,308,847 | 1,036,693 |
| Total EMEA | 2,123,971 | 1,750,910 | 1,366,739 |
| Asia Pacific | 574,432 | 482,259 | 402,742 |
| Total revenues | $5,215,304 | $4,358,603 | $3,534,647 |
The Company provides different deployment options for its offerings. Cloud offerings provide customers the right to use the Company’s software in a cloud-based infrastructure that the Company provides. Data Center offerings are on-premises term license agreements for the Company’s Data Center products, which are software licensed for a specified period, and include support and maintenance services that are bundled with the license for the term of the license period. Marketplace and other offerings mainly include fees received for sales of third-party apps in the Atlassian Marketplace and services like premier support, advisory services, and training services. Premier support consists of subscription-based arrangements for a higher level of support across different deployment options, and revenues from this offering are included in Subscription revenues within the Company’s Consolidated Statements of Operations.
The revenues from Server offerings consists of revenue from maintenance services since the Company no longer sells perpetual licenses for its Server offerings. The Company generally ended maintenance and support for these Server offerings in February 2024.
The Company’s revenues by deployment options are as follows (in thousands):
| Fiscal Year Ended June 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Cloud | $3,447,427 | $2,698,899 | $2,085,498 |
| Data Center | 1,467,167 | 1,208,498 | 819,251 |
| Server | — | 177,645 | 400,519 |
| Marketplace and other | 300,710 | 273,561 | 229,379 |
| Total revenues | $5,215,304 | $4,358,603 | $3,534,647 |
Deferred Revenue
The Company records deferred revenues when cash payments are received or due in advance of the Company satisfying its performance obligations, including amounts that are refundable. The changes in the deferred revenue are as follows (in thousands):
| Fiscal Year Ended June 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Balance, beginning of period | $2,114,736 | $1,545,479 |
| Additions | 5,581,822 | 4,927,860 |
| Revenue | (5,215,304) | (4,358,603) |
| Balance, end of period | $2,481,254 | $2,114,736 |
For fiscal years 2025 and 2024, approximately 34% and 31% of revenue recognized was from the deferred revenue balances at the beginning of each fiscal year, respectively.
Deferred Contract Acquisition Costs
The changes in the balances of deferred contract acquisition costs are as follows (in thousands):
| Fiscal Year Ended June 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Balance, beginning of period | $79,711 | $53,604 |
| Additions | 96,869 | 51,326 |
| Amortization expense | (40,240) | (25,219) |
| Balance, end of period | $136,340 | $79,711 |
| Deferred contract acquisition costs included in: | ||
| Prepaid expenses and other current assets | $50,233 | $29,170 |
| Other non-current assets | 86,107 | 50,541 |
| Total | $136,340 | $79,711 |
The Company periodically reviews these deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. There wereno impairment losses recorded during the periods presented.
- Geographic Information
The Company’s long-lived assets by geographic regions are as follows (in thousands):
| As of June 30, | ||
|---|---|---|
| 2025 | 2024 | |
| United States | $168,841 | $189,468 |
| Australia | 54,073 | 47,082 |
| India | 34,909 | 6,522 |
| All other countries | 16,422 | 15,712 |
| Total long-lived assets | $274,245 | $258,784 |
Long-lived assets for this purpose consist of property and equipment and operating lease right-of-use assets.
- Stockholders' Equity
Common Stock
As of June 30, 2025, the Company’s common stock consists of Class A Common Stock and Class B Common Stock, each of which has a par value of $0.00001. Each share of Class B Common Stock will convert automatically intoone share of Class A Common Stock in the following circumstances: (1) upon the written consent of the holders of at least 66.66% of the total number of outstanding shares of Class B Common Stock; (2) if the aggregate number of shares of Class B Common Stock then outstanding comprises less than ten percent (10%) of the total number of shares of Class A Common Stock and Class B Common Stock then outstanding; and (3) upon any transfer to a person that is not a permitted transferee described in the Company’s amended and restated certificate of incorporation.
Any dividend declared by the Company must be paid on the Class A Common Stock and the Class B Common Stock pari passu as if they were all stock of the same class. Additionally, upon the liquidation, dissolution, or winding up of the Company, whether voluntary or involuntary, holders of Class A Common Stock and Class B Common Stock will be entitled to receive ratably on a per share basis all assets of the Company available for distribution to its stockholders, unless disparate or different treatment of the shares of each such class is approved by the affirmative vote of the holders of a majority of the outstanding shares of Class A Common Stock and by the affirmative vote of the holders of a majority of the outstanding shares of Class B Common Stock, each voting separately as a class.
Each share of Class A Common Stock is entitled toone vote. Each share of Class B Common Stock is entitled to 10 votes.
Preferred Stock
The Company’s board of directors has the authority to issue up to 10 million shares of preferred stock in one or more series. The Company’s board of directors may designate the rights, preferences, privileges, and restrictions of the preferred stock, including voting rights, dividend rights, conversion rights, redemption privileges, and liquidation preferences, the right to elect directors to and increase or decrease the number of shares of any series. As of June 30, 2025 and 2024, no shares of preferred stock were outstanding.
Stock-based Compensation
The Company maintains the Atlassian Corporation Amended and Restated 2015 Share Incentive Plan (the “2015 Plan”), and the Atlassian Corporation Amended and Restated 2015 Employee Share Purchase Plan (the “ESPP” and, together with the 2015 Plan, the “Incentive Plans”). At June 30, 2025, the Company had 28,121,651 shares of its common stock available for future issuance under the 2015 Plan. The Company currently does not have common stock outstanding or open offering periods under the ESPP.
RSU grants generally vest evenly over four years on a quarterly basis. Prior to April 2021 for existing employees and September 2023 for new employees, RSU grants generally vested over four years with 25% vesting on theone year anniversary of the grant date and 1/12 th of the remaining RSUs vesting on a quarterly basis over the remaining three years.
A summary of RSU activity forfiscal year 2025 is as follows (in thousands except share and per share data):
| Number of Shares | Weighted Average Grant Date Fair Value | Aggregate Intrinsic Value | |
|---|---|---|---|
| Balance as of June 30, 2024 | 12,696,964 | $213.13 | $2,245,839 |
| Granted | 12,579,661 | 179.10 | — |
| Vested | (6,400,145) | 207.38 | $1,537,447 |
| Forfeited or cancelled | (2,298,460) | 195.96 | — |
| Balance as of June 30, 2025 | 16,578,020 | $190.98 | $3,366,830 |
The weighted-average grant date fair value of RSUs granted in fiscal years 2024 and 2023 was $199.66 and $221.87, respectively. The total intrinsic value of the RSUs vested in fiscal years 2024 and 2023 was $950.3 million and $617.0 million, respectively. The income tax benefit recognized related to awards vested in fiscal years 2025, 2024 and 2023 was $335.1 million, $218.7 million, and $156.5 million, respectively. As of June 30, 2025, total compensation cost not yet recognized in the consolidated financial statements related to employee and director RSU awards was $2.4 billion, which is expected to be recognized over a weighted-average period of 2.6 years.
During fiscal year 2025, the Company didnot grant any RSAs. During fiscal year 2024, the Company granted RSAs for 301,751 shares of Class A Common Stock in connection with a business combination. As of June 30, 2025 and 2024, there were RSAs for 90,083 and 156,856 shares of Class A Common Stock outstanding, respectively. These outstanding RSAs are subject to forfeiture or repurchase at the original exercise price during the repurchase period following employee termination, as applicable. The total aggregate intrinsic value of outstanding RSAs was $18.3 million and $27.7 million as of June 30, 2025 and 2024, respectively.
Of the total stock-based compensation expense, costs recognized for awards granted to non-employees were immaterial for all periods presented.
Share Repurchase Program
In January 2023, the Board of Directors authorized a program to repurchase up to $1.0 billion of the Company’s outstanding Class A Common Stock (the “2023 Repurchase Program”).
In September 2024, the Board of Directors authorized a new program under which the Company may repurchase up to an additional $1.5 billion of the Company’s outstanding Class A Common Stock (the “2024 Repurchase Program” and, together with the 2023 Repurchase Program, the “Repurchase Programs”). The 2024 Repurchase Program commenced in April 2025 following the completion of the 2023 Repurchase Program.
The 2024 Repurchase Program does not have a fixed expiration date, may be suspended or discontinued at any time, and does not obligate the Company to repurchase any specific dollar amount or to acquire any specific number of shares. The Company may repurchase shares of Class A Common Stock from time to time through open market purchases, in privately negotiated transactions, or by other means, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, in accordance with applicable securities laws and other restrictions. The timing, manner, price, and amount of any repurchases will be determined by the Company at its discretion and will depend on a variety of factors, including business, economic, and market conditions, prevailing stock prices, corporate and regulatory requirements, and other considerations.
During fiscal year 2025, the Company repurchased and subsequently retired approximately 4.0 million shares of its Class A Common Stock for approximately $780.7 million at an average price per share of $196.02. All repurchases were made in open market transactions. As of June 30, 2025, $1.2 billion of the Company’s Class A Common Stock remained available for repurchase under the 2024 Repurchase Program.
- Net Loss Per Share
The Company computes net loss per share of Class A and Class B Common Stock using the two-class method. As the liquidation and dividend rights for both Class A and Class B Common Stock are identical, the net loss is allocated on a proportionate basis to the weighted-average number of shares of common stock outstanding for the period. Basic net loss per share attributable to Class A and Class B stockholders is computed by dividing the net loss by the weighted-average number of Class A and Class B Common Stock outstanding during the period.
For the calculation of diluted net loss per share, net loss for basic EPS is adjusted by the effect of dilutive securities, including awards under the Company’s equity compensation plans. The dilutive potential shares of common stock are computed using the treasury stock method or the as-if converted method, as applicable. Since the Company is in a loss position for all periods reported, basic and diluted net loss per share are the same for all periods as the inclusion of potential dilutive shares would have been anti-dilutive.
The following tables present the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data):
| Fiscal Year Ended June 30, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | 2023 | ||||
| Class A | Class B | Class A | Class B | Class A | Class B | |
| Numerator: | ||||||
| Net Loss | $(160,050) | $(96,637) | $(181,587) | $(118,932) | $(283,907) | $(202,854) |
| Denominator: | ||||||
| Weighted-average shares outstanding, basic and diluted | 163,230 | 98,557 | 156,580 | 102,553 | 149,493 | 106,814 |
| Net loss per share, basic and diluted | $(0.98) | $(0.98) | $(1.16) | $(1.16) | $(1.90) | $(1.90) |
The potential weighted average dilutive securities that were not included in the dilutive earnings per share calculation because the effect would be anti-dilutive are as follows (shares in thousands):
| Fiscal Year Ended June 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Class A Common Stock RSU awards | 7,423 | 8,320 | 7,426 |
| Class A Common Stock restricted stock awards | 29 | 23 | 17 |
| Total potentially dilutive securities | 7,452 | 8,343 | 7,443 |
- Income Taxes
The components of loss before provision for income taxes by U.S. and foreign jurisdictions consist of the following (in thousands):
| Fiscal Year Ended June 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Domestic | $(137,403) | $(139,687) | $(25,250) |
| Foreign | 38,508 | 54,280 | (285,886) |
| Total | $(98,895) | $(85,407) | $(311,136) |
The provision for income taxes consists of the following (in thousands):
| Fiscal Year Ended June 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Current: | |||
| Federal | $(1,249) | $2,134 | $4,327 |
| State | 4,534 | 3,969 | 1,045 |
| Foreign | 149,908 | 209,002 | 162,072 |
| Total | 153,193 | 215,105 | 167,444 |
| Deferred: | |||
| Federal | 927 | (14,030) | 1,467 |
| State | 1,814 | 3,680 | (1,066) |
| Foreign | 1,858 | 10,357 | 7,780 |
| Total | 4,599 | 7 | 8,181 |
| Total provision for income taxes | $157,792 | $215,112 | $175,625 |
The effective income tax rate differs from the federal statutory income tax rate applied to the loss before income taxes due to the following (in thousands):
| Fiscal Year Ended June 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Tax at federal statutory rate | $(20,768) | $(17,935) | $(65,339) |
| State, net of the federal benefit | 28,097 | 16,362 | 13,042 |
| Effects of non-U.S. operations | 7,332 | (14,575) | 15,163 |
| Tax credits | (233,946) | (151,912) | (99,398) |
| Stock-based compensation | 94,305 | 123,719 | 80,471 |
| Non-deductible executive compensation | 10,462 | 6,721 | 6,022 |
| Australian R&D deductions forgone in lieu of R&D credit | 29,169 | 29,502 | 30,303 |
| Foreign taxes | 1,159 | (131) | 2,457 |
| Basis difference in investments | (34,562) | 14,615 | (43,564) |
| Change in reserves | 29,886 | 32,505 | 132,528 |
| Change in valuation allowance | 239,975 | 174,994 | 98,613 |
| Other | 6,683 | 1,247 | 5,327 |
| Provision for income taxes | $157,792 | $215,112 | $175,625 |
| Effective Tax Rate (%) | (160)% | (252)% | (56)% |
Significant components of the Company’s deferred tax assets and deferred tax liabilities are shown below (in thousands). Where necessary, a valuation allowance has been recognized to offset the Company’s deferred tax assets by the amount of any tax benefits that are not expected to be realized.
| As of June 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Deferred tax assets: | ||
| Property and equipment | $11,028 | $7,748 |
| Loss carryforwards | 615,687 | 779,554 |
| Credit carryforwards | 401,629 | 252,444 |
| Operating lease liabilities | 56,962 | 62,300 |
| Basis differences in investments | 2,040,203 | 1,811,999 |
| Provisions, accruals, and prepayments | 66,735 | 58,820 |
| Deferred revenue | 317,761 | 306,629 |
| Capitalized research and development | 113,489 | 81,503 |
| Other, net | 571 | 717 |
| Total deferred tax assets | 3,624,065 | 3,361,714 |
| Less valuation allowance | (3,549,451) | (3,268,643) |
| Total deferred tax assets, net of valuation allowance | 74,614 | 93,071 |
| Deferred tax liabilities: | ||
| Unrealized foreign currency exchange losses | 1,522 | 2,705 |
| Unrealized investment gains | 4,163 | 1,007 |
| Operating right of use assets | 46,348 | 47,825 |
| Stock-based compensation | 7,205 | 5,526 |
| Intangible assets | 35,495 | 52,461 |
| Total deferred tax liabilities | 94,733 | 109,524 |
| Net deferred tax liabilities | $(20,119) | $(16,453) |
The Company recorded a valuation allowance of $3.5 billion, $3.3 billion and $3.0 billion as of June 30, 2025, 2024, and 2023, respectively, primarily relating to the basis difference of the U.S. investment in a wholly owned partnership, U.S. net operating loss and credit carryforwards, and the deferred revenue deferred tax assets. The change in valuation allowance as of June 30, 2025, 2024 and 2023, was primarily related to an increase in the basis difference of the US investment in a wholly owned partnership, certain credit carryforwards, and the deferred revenue deferred tax assets, offset by the utilization of U.S. federal and state net operating losses. The Company regularly assesses the realizability of its deferred tax assets and establishes a valuation allowance if it is more likely than not that some or all of its deferred tax assets will not be realized. The Company evaluates and weighs all positive and negative evidence such as historic results, future reversals of deferred tax liabilities, projected future taxable income, as well as prudent and feasible tax planning strategies. The assessment requires significant judgment and is performed in each of the applicable jurisdictions. The Company intends to maintain a full valuation allowance on its federal deferred tax assets in the U.S. and Australia until there is sufficient positive evidence to support their reversal.
As of June 30, 2025, the Company had U.S. federal, state, and foreign net operating loss carryforwards of $633.4 million tax effected. Of the $538.1 million tax effected U.S. federal net operating loss carryforwards, $537.9 million may be carried forward indefinitely, and the remaining $0.2 million will begin to expire in 2032. The state net operating loss carryforwards of $95.1 million tax effected begin to expire in 2026. The foreign net operating loss carryforwards may be carried forward indefinitely. As of June 30, 2025, the Company also had research and development U.S. federal and state tax credits of $244.7 million and $117.9 million, respectively, and U.S. federal foreign tax credits of $50.6 million. The U.S. federal research and development credits will begin expiring in 2036 if not utilized, and the U.S. federal foreign tax credits will begin expiring in 2034. The state tax credit carryforwards do not expire except for the state research and development credits of Texas which will begin to expire in June 2038.
Utilization of the Company’s US net operating loss and tax credit carryforwards may be subject to annual limitation due to the ownership change limitations provided by the Internal Revenue Code and similar state provisions. Such an annual limitation could result in the expiration of the net operating loss and tax credit carryforwards before utilization. As of June 30, 2025, the Company also had Polish R&D credits of $13.2 million, which will begin to expire in 2028.
On July 4, 2025, the U.S. government enacted The One Big Beautiful Bill Act (“OBBBA”) which includes, among other provisions, changes to the U.S. corporate income tax system such as allowing of immediate expensing of qualifying domestic research and development expenses and permanent extensions of certain provisions within the Tax Cuts and Jobs Act. Certain provisions are effective for the Company beginning in fiscal year 2026. The Company is currently evaluating the future impact of these tax law changes on its consolidated financial statements.
The Organization for Economic Co-operation and Development released Pillar Two model rules defining a 15% global minimum tax for multinational corporations. Many countries in which the Company operates, including the member states of the EU, have enacted Pillar Two. Pillar Two rules began to apply to the Company in fiscal year 2025. Based on enacted laws, Pillar Two is not expected to materially impact the Company’s effective tax rate or cash flows. New legislation or guidance could change the Company’s current assessment.
U.S. income tax has not been recognized on the excess of the amount for financial reporting over the tax basis of investment in foreign subsidiaries that is indefinitely reinvested outside the United States. Un-remitted earnings become taxable upon repatriation of assets from the subsidiary or a sale or liquidation of the subsidiary. The amount of such un-remitted earnings is approximately $1,072.6 million as of June 30, 2025, and the corresponding unrecognized deferred tax liability is not material.
The Company recognizes the tax benefit of an uncertain tax position only if it concludes it is more likely than not that the position is sustainable upon examination by the taxing authority, based on the technical merits. The tax benefit recognized is measured as the largest amount of benefit which is greater than 50 percent likely to be realized upon settlement with the taxing authority. A reconciliation of the beginning and ending balance of total unrecognized tax benefits is as follows (in thousands):
| Fiscal Year Ended June 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Beginning of the period | $104,453 | $122,302 | $53,483 |
| Tax positions taken in prior period: | |||
| Gross increases | 105 | 10,887 | 112,781 |
| Gross decreases | (4,547) | — | (198) |
| Tax positions taken in current period: | |||
| Gross increases | 36,871 | 25,707 | 15,171 |
| Settlements | — | (53,648) | (57,004) |
| Lapse of statute of limitations | — | — | (32) |
| Currency translation effect | — | (795) | (1,899) |
| End of period | $136,882 | $104,453 | $122,302 |
As of June 30, 2025, 2024, and 2023, the Company had gross unrecognized tax benefits of approximately $0.4 million, $10.9 million, and $113.2 million, respectively, that would impact the effective tax rate if recognized.
The Company files income tax returns in the U.S. federal jurisdiction, various state jurisdictions, Australia, and in various other international jurisdictions. Tax years 2013 and forward generally remain open for examination for U.S. federal and state tax purposes. Tax years 2018 and forward generally remain open for examination for non-U.S. tax purposes. To the extent utilized in future years’ tax returns, net operating loss carryforwards as of June 30, 2025, and 2024 will remain subject to examination until the respective tax year is closed.
There are differing interpretations of tax laws and regulations, and as a result, disputes may arise with tax authorities involving issues of the timing and amount of deductions and allocations of income among various tax jurisdictions. The Company believes that adequate amounts have been reserved for any adjustments that may ultimately result from these examinations. It is reasonably possible that an immaterial decrease in unrecognized tax benefits may occur during the next 12 months.
During the year ended June 30, 2024, the Company finalized an Advanced Pricing Arrangement with the Australian Taxation Office with respect to its transfer pricing arrangements between Australia and the U.S. that covers the tax years ended June 30, 2019 to June 30, 2025. Pursuant to the terms of the agreement, the Company made a cash settlement payment of approximately $60.5 million of taxes and interest.
The Company believes it is reasonably possible that the balance of unrecognized tax benefits could change in the next 12 months due to the completion of ongoing income tax audits. The estimated range of the change is a decrease of $4.2 million to an increase of $5.2 million.
The Company has not recognized any interest and penalties related to unrecognized tax benefits in the income tax provision during fiscal year 2025 and recognized approximately $0.6 million and $5.8 million during fiscal years 2024 and 2023, respectively. As of June 30, 2025 and 2024, there wereno accrual balances, and as of June 30, 2023 the accrual balances were $5.8 million.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.